Literature DB >> 24085400

Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm.

Stefano Volpato1, Lara Bianchi, Antonio Cherubini, Francesco Landi, Marcello Maggio, Elisabetta Savino, Stefania Bandinelli, Gian Paolo Ceda, Jack M Guralnik, Giovanni Zuliani, Luigi Ferrucci.   

Abstract

BACKGROUND: Muscle impairment is a common condition in older people and a powerful risk factor for disability and mortality. The aim of this study was to apply the European Working Group on Sarcopenia in Older People criteria to estimate the prevalence and investigate the clinical correlates of sarcopenia, in a sample of Italian community-dwelling older people.
METHODS: Cross-sectional analysis of 730 participants (74% aged 65 years and older) enrolled in the InCHIANTI study. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People criteria using bioimpedance analysis for muscle mass assessment. Logistic regression analysis was used to identify the factors independently associated with sarcopenia.
RESULTS: Sarcopenia defined by the European Working Group on Sarcopenia in Older People criteria increased steeply with age (p < .001), with 31.6% of women and 17.4% of men aged 80 years or older being affected by this condition. Higher education (odds ratio: 0.85; 95% CI: 0.74-0.98), lower insulin-like growth factor I (lowest vs highest tertile, odds ratio: 3.89; 95% CI: 1.03-14.1), and low bioavailable testosterone (odds ratio: 2.67; 95% CI: 1.31-5.44) were independently associated with the likelihood of being sarcopenic. Nutritional intake, physical activity, and level of comorbidity were not associated with sarcopenia.
CONCLUSIONS: Sarcopenia identified by the European Working Group on Sarcopenia in Older People criteria is a relatively common condition in Italian octogenarians, and its prevalence increases with aging. Correlates of sarcopenia identified in this study might suggest new approaches for prevention and treatment of sarcopenia.

Entities:  

Keywords:  Community-dwelling older people; Frail elderly.; Sarcopenia

Mesh:

Year:  2013        PMID: 24085400      PMCID: PMC3968828          DOI: 10.1093/gerona/glt149

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  32 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Effect of 10 days of bed rest on skeletal muscle in healthy older adults.

Authors:  Patrick Kortebein; Arny Ferrando; Juan Lombeida; Robert Wolfe; William J Evans
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

3.  Dynapenia and aging: an update.

Authors:  Todd M Manini; Brian C Clark
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-03-28       Impact factor: 6.053

4.  Low testosterone levels and the risk of anemia in older men and women.

Authors:  Luigi Ferrucci; Marcello Maggio; Stefania Bandinelli; Shehzad Basaria; Fulvio Lauretani; Alessandro Ble; Giorgio Valenti; William B Ershler; Jack M Guralnik; Dan L Longo
Journal:  Arch Intern Med       Date:  2006-07-10

5.  Midlife physical activity and mobility in older age: The InCHIANTI study.

Authors:  Kushang V Patel; Antonia K Coppin; Todd M Manini; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Jack M Guralnik
Journal:  Am J Prev Med       Date:  2006-08-02       Impact factor: 5.043

6.  Prevalence and risk factors of sarcopenia among nursing home older residents.

Authors:  Francesco Landi; Rosa Liperoti; Domenico Fusco; Simona Mastropaolo; Davide Quattrociocchi; Anna Proia; Andrea Russo; Roberto Bernabei; Graziano Onder
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-03-10       Impact factor: 6.053

7.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

Authors:  Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni
Journal:  J Am Med Dir Assoc       Date:  2011-03-04       Impact factor: 4.669

8.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

Review 9.  Age-related changes in the structure and function of skeletal muscles.

Authors:  John A Faulkner; Lisa M Larkin; Dennis R Claflin; Susan V Brooks
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-11       Impact factor: 2.557

10.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

View more
  83 in total

1.  Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II).

Authors:  D Spira; K Norman; J Nikolov; I Demuth; E Steinhagen-Thiessen; R Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-04-16       Impact factor: 1.281

2.  Financial impact of sarcopenia on hospitalization costs.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; S Ferreira; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2016-05-11       Impact factor: 4.016

3.  Incidence, Risk Factors, and the Protective Effect of High Body Mass Index against Sarcopenia in Suburb-Dwelling Elderly Chinese Populations.

Authors:  P Han; J Zhao; Q Guo; J Wang; W Zhang; S Shen; X Wang; R Dong; Y Ma; L Kang; L Fu; L Jia; X Han; Z He; Y Bao; L Wang; K Niu
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 4.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

5.  [Sarcopenia and frailty in neurology].

Authors:  W Maetzler; M Drey; A H Jacobs
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

6.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

7.  Insulin-Like Growth Factor-1 Related to Disability Among Older Adults.

Authors:  Takehiko Doi; Hiroyuki Shimada; Hyuma Makizako; Kota Tsutsumimoto; Ryo Hotta; Sho Nakakubo; Takao Suzuki
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-30       Impact factor: 6.053

8.  Tinetti mobility test is related to muscle mass and strength in non-institutionalized elderly people.

Authors:  Francesco Curcio; Claudia Basile; Ilaria Liguori; David Della-Morte; Gaetano Gargiulo; Gianluigi Galizia; Gianluca Testa; Assunta Langellotto; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Age (Dordr)       Date:  2016-08-26

9.  The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study.

Authors:  Lara Bianchi; Luigi Ferrucci; Antonio Cherubini; Marcello Maggio; Stefania Bandinelli; Elisabetta Savino; Gloria Brombo; Giovanni Zuliani; Jack M Guralnik; Francesco Landi; Stefano Volpato
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-02       Impact factor: 6.053

10.  Physical activity and incidence of sarcopenia: the population-based AGES-Reykjavik Study.

Authors:  Donja M Mijnarends; Annemarie Koster; Jos M G A Schols; Judith M M Meijers; Ruud J G Halfens; Vilmundur Gudnason; Gudny Eiriksdottir; Kristin Siggeirsdottir; Sigurdur Sigurdsson; Pálmi V Jónsson; Osorio Meirelles; Tamara Harris
Journal:  Age Ageing       Date:  2016-05-17       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.